InsidersTradesSigma
Explore the detailed record of transactions filed by Magnus Olafsson Corfitzen, 首席执行官. Director active across 2 companies, notably Ascelia Pharma AB. Aggregated, 2 filings have been published. Activity tracked since 15 April 2025. The latest transaction was filed on 25 November 2025 (Purchase). Regulator: FIN-FSA. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Magnus Olafsson Corfitzen is the CEO of Ascelia Pharma AB. He is responsible for the strategic direction of the company and the day-to-day management of operations. With a strong background in the pharmaceutical sector, Magnus is committed to promoting innovation and achieving Ascelia's growth objectives. His leadership is crucial for the development of new treatments and meeting patient needs.